These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 11420696

  • 1. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein.
    Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM.
    Oncogene; 2001 May 17; 20(22):2844-53. PubMed ID: 11420696
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2.
    Tatarelli C, Linnenbach A, Mimori K, Croce CM.
    Genomics; 2000 Aug 15; 68(1):1-12. PubMed ID: 10950921
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines.
    Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK, Black DM.
    Oncogene; 1999 Mar 11; 18(10):1881-90. PubMed ID: 10086342
    [Abstract] [Full Text] [Related]

  • 4. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG.
    Cancer Res; 2001 Sep 15; 61(18):6688-92. PubMed ID: 11559536
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J, Flanagan J, Phillips WA, Chenevix-Trench G, Arnold J.
    Br J Cancer; 2003 Jan 27; 88(2):270-6. PubMed ID: 12610513
    [Abstract] [Full Text] [Related]

  • 6. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
    Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA.
    Cancer Res; 2000 Sep 01; 60(17):4907-12. PubMed ID: 10987305
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
    Knowles MA, Aveyard JS, Taylor CF, Harnden P, Bass S.
    Cancer Lett; 2005 Jul 08; 225(1):121-30. PubMed ID: 15922864
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.
    Oncogene; 2003 Mar 13; 22(10):1580-8. PubMed ID: 12629521
    [Abstract] [Full Text] [Related]

  • 10. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F.
    Oncogene; 2003 Jul 17; 22(29):4611-6. PubMed ID: 12881718
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterisation of chicken TES and its role in cell spreading and motility.
    Griffith E, Coutts AS, Black DM.
    Cell Motil Cytoskeleton; 2004 Mar 17; 57(3):133-42. PubMed ID: 14743347
    [Abstract] [Full Text] [Related]

  • 13. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.
    Hesson L, Dallol A, Minna JD, Maher ER, Latif F.
    Oncogene; 2003 Feb 13; 22(6):947-54. PubMed ID: 12584574
    [Abstract] [Full Text] [Related]

  • 14. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA, Lee KY, Liu Y, Emilion G, Finch J, Soosay AE, Charnock FM, Beck S, Dunham I, Mungall AJ, Ganesan TS.
    Oncogene; 2007 Feb 01; 26(5):683-700. PubMed ID: 16878154
    [Abstract] [Full Text] [Related]

  • 15. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M, McKenzie OL, Bais AJ, Martin JM, Secker GA, Seshadri R, Powell JA, Hinze SJ, Gardner AE, Spendlove HE, O'Callaghan NJ, Cleton-Jansen AM, Cornelisse C, Whitmore SA, Crawford J, Kremmidiotis G, Sutherland GR, Callen DF.
    Cancer Res; 2002 Aug 15; 62(16):4599-604. PubMed ID: 12183414
    [Abstract] [Full Text] [Related]

  • 16. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF.
    Genes Chromosomes Cancer; 2004 Jul 15; 40(3):190-203. PubMed ID: 15138999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishizaki K, Shimizu K.
    Oncogene; 2002 Jun 27; 21(28):4462-70. PubMed ID: 12080476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours.
    Brown VL, Proby CM, Barnes DM, Kelsell DP.
    Br J Cancer; 2002 Jul 15; 87(2):208-11. PubMed ID: 12107844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.